3/27/2024 | GNIG | Moody’s turns Sanofi outlook to positive
|
5/19/2023 | GNIG | Fitch lifts Sanofi
|
5/23/2022 | GNIG | Fitch revises Sanofi outlook to positive
|
3/31/2022 | GN | New Issue: Sanofi prices €650 million of 1.25% sustainability-linked notes
|
1/21/2022 | EULM | Sanofi to redeem €850 million 0% notes due 2022 on Feb. 21
|
12/20/2021 | EULM | Sanofi calls €1 billion 1.125% notes due 2022 on Jan. 10
|
7/22/2021 | SP | New Issue: Credit Suisse sells $1.51 million contingent coupon autocallables on three stocks
|
6/3/2020 | IG | S&P changes Sanofi view to stable
|
4/24/2020 | SP | New Issue: Goldman prices $1.73 million leveraged basket-linked notes on 19 stocks
|
3/13/2020 | SP | New Issue: Credit Suisse $1.07 million contingent coupon autocallable yield notes on three stocks
|
6/19/2019 | IG | Fitch downgrades Sanofi
|
5/28/2019 | SP | Credit Suisse to price buffered return equity notes on stock basket
|
4/29/2019 | IG | S&P lowers Sanofi view to negative
|
6/19/2018 | CVLM | Sanofi receives €0.8 million of Ablynx convertibles in squeeze out
|
6/13/2018 | IG | New Issue: Sanofi details $2 billion issue of notes priced in two tranches
|
6/12/2018 | EMHYPFPV | Market Commentary: HSBC, Sanofi, Alexandria Real Estate, Kommuninvest price; AT&T firms on deal approval
|
6/12/2018 | IG | Market Commentary: HSBC, Sanofi, Alexandria Real Estate, Kommuninvest price; AT&T firms on deal approval
|
6/12/2018 | IG | New Issue: Sanofi prices $2 billion of five-, 10-year notes
|
6/12/2018 | IG | Market Commentary: Morning Commentary: Sanofi, Alexandria Real Estate offer notes; Kommuninvest on tap
|
6/12/2018 | IG | Sanofi prepares to price dollar fixed-rate notes in two tranches
|
5/14/2018 | CVLM | Sanofi receives tenders for €97.5 million of Ablynx convertibles
|
3/29/2018 | CVLM | Sanofi to start tender for Ablynx convertibles on April 4, ups price
|
2/1/2018 | IG | S&P affirms Sanofi
|
1/29/2018 | CVLM | Ablynx convertibles to be purchased at €310,992 in Sanofi offer
|
1/22/2018 | IG | Sanofi plans to use new debt for $11.6 billion Bioverativ acquisition
|
2/2/2017 | SP | New Issue: RBC prices $4.05 million direct investment notes tied to 20 stocks
|
1/9/2017 | SP | RBC plans direct investment notes linked to basket of 20 stocks
|
12/16/2016 | IG | Fitch revises Sanofi to negative
|
9/1/2016 | SP | New Issue: JPMorgan prices $3.72 million trigger autocallable contingent yield notes tied to Sanofi
|
8/24/2016 | SP | JPMorgan plans trigger autocallable contingent yield notes tied to Sanofi
|
2/10/2016 | SP | RBC plans buffered return optimization notes linked to European stocks
|
4/16/2015 | SP | New Issue: Barclays prices $1.38 million seven-year notes linked to basket of ADSs
|
1/2/2015 | SP | Bank of the West plans seven-year income CDs linked to Dividend Kings
|
7/9/2014 | SP | JPMorgan plans to price return notes linked to basket of 16 stocks
|
5/3/2013 | IG | S&P upgrades Sanofi
|
4/3/2013 | IG | New Issue: France's Sanofi sells $1.5 billion 1.25% five-year notes at 62 bps over Treasuries
|
4/3/2013 | IG | Market Commentary: Sanofi, Avery Dennison, Barclays price as supply grows; Colonial Pipeline notes trade flat
|
4/3/2013 | IG | Sanofi talks five-year note offering for Wednesday sale at Treasuries plus 65 bps area
|
3/28/2013 | IG | Moody's upgrades Sanofi
|
5/23/2012 | IG | Moody's: Sanofi view positive
|
12/20/2011 | IG | Fitch: Sanofi outlook stable
|
9/27/2011 | IG | New Issue: Sanofi sells upsized $1 billion 1.2% three-year notes at 83 bps over Treasuries
|
9/27/2011 | IG | Market Commentary: Sanofi, Qwest, McDonald's among names tapping market despite high concessions; bonds firm
|